Information Collection
Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements (Cognitive Interviews)
IC 216972 under ICR 201409-0910-020 · OMB 0910-0695.
⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0695 can be found here:
Documents and Forms
| Document Name | Document Type |
|---|---|
| Other-Screener | |
| Other-Testing Guide | |
|
OMB Justification Memo | IC Document |